| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |